I. Dindarloo Inaloo, et al.
MolecularCatalysis492(2020)110915
obtained from the catalyst before and after the reaction (Fig. 6). Ac-
cording to the fitted data, the deconvoluted peaks at binding energy
855.9 eV and 861.8 eV are attributed to Ni 2p3/2 and peaks at 872.2 eV
and 879.8 eV constitutes to Ni 2p1/2 for fresh catalyst that can be in-
dexed to Ni2+ (Fig. 6a). [98] Besides, the XPS patterns of recovered
catalyst show the peaks of both Ni2+ and Ni(0) (Fig. 6b). The peaks at
around 852.4 eV and 872.2 eV were assigned to the Ni 2p3/2 and Ni 2p1/
industries as well as in the synthesis of biologically significant com-
pounds in which the safety, environmental and financial issues are of
greater concern.
Funding
No funding was received for this work.
Intellectual property
levels in the Ni(0) which are in good agreement with the literature
2
report [99]. The above phenomena supported that the reaction pro-
ceeded via the traditional Ni2+/Ni(0) cycle mechanism.
The recyclability and high stability of the economically and eco-
friendly catalytic systems are so important in the industry and de-
signing the green and effective synthetic pathways. Therefore, we fo-
cused on the investigation of stability and reusability of catalyst under
the optimal reaction conditions. Therefore, the model reaction was
chosen to be tested in the efficiency of catalyst behavior. After com-
pleting the model reaction, the magnetic heterogeneous catalyst was
separated by using an external magnet and washed with ethanol, dried
at 60 °C under vacuum and prepared for using in the next runs. As
shown in Fig. 7, after seven cycles just the insignificant decrease in the
catalytic activity was observed. Surprisingly, the decrease in the effi-
cacy of catalyst after 7 runs is only 3%.
The morphology and stability of catalyst against the aggregation
have been investigated after seventh run (Fig. 8). As shown in Fig. 8a
and 8b, the TEM and FE-SEM images of recovered magnetic nano-
particles after the seventh cycle revealed that almost all Fe3O4@SiO2-
EDTA-Ni(II) particles are spherical in shape as the same as fresh catalyst
indicating that the aggregation of nanoparticles is venial. Moreover, the
hydrodynamic diameter of the catalyst was studied by the DLS tech-
nique (Fig. 8c) in which insignificant aggregation was observed for
reused nanocatalyst and the size distribution is centered at around
37 nm.
Additionally, the catalyst was investigated by Inductively Coupled
Plasma (ICP) analysis after the last run to determine the amount of
nickel leaching. Accordingly, the amount of loaded nickel on the re-
covered catalyst was measured to be 0.54 mmol/g. Propitiously, the ICP
analysis after the seventh run showed less than 1% nickel leaching.
Moreover, to determine the responsibility of nickel moiety for carrying
out the model reaction, the hot filtration test was performed. When the
reaction time of the model reaction reached the half time of reaction
quenching, the catalyst nanoparticles were taken out from the reaction
mixture by an external magnetic field and the residue was allowed to be
stirred under the reaction conditions. The monitoring of reaction mix-
ture by TLC did not show any considerable progress. These results
showed that only a few species of nickel may exist in the solution phase
and the main responsible species that catalyzes the model reaction, is
the Fe3O4@SiO2-EDTA-Ni(II) nanoparticles. All of these data confirmed
the high stability and reusability of the catalyst under these reaction
conditions.
We confirm that we have given due consideration to the protection
of intellectual property associated with this work and that there are no
impediments to publication, including the timing of publication, with
respect to intellectual property. In so doing we confirm that we have
followed the regulations of our institutions concerning intellectual
property.
Research ethics
We further confirm that any aspect of the work covered in this
manuscript that has involved human patients has been conducted with
the ethical approval of all relevant bodies and that such approvals are
acknowledged within the manuscript.
IRB approval was obtained (required for studies and series of 3 or
more cases)
Written consent to publish potentially identifying information, such
as details or the case and photographs, was obtained from the patient(s)
or their legal guardian(s).
Authorship
The International Committee of Medical Journal Editors (ICMJE)
recommends that authorship be based on the following four criteria:
Substantial contributions to the conception or design of the work; or
the acquisition, analysis, or interpretation of data for the work; AND
Drafting the work or revising it critically for important intellectual
content; AND
Final approval of the version to be published; AND
Agreement to be accountable for all aspects of the work in ensuring
that questions related to the accuracy or integrity of any part of the
work are appropriately investigated and resolved.
Declaration of Competing Interest
We wish to confirm that there are no known conflicts of interest
associated with this publication and there has been no significant fi-
nancial support for this work that could have influenced its outcome.
Acknowledgments
4. Conclusion
The authors gratefully acknowledge the financial support of this
work by the Research Council of Shiraz University.
We have demonstrated a general, convenient and highly efficient
protocol for the N-arylation of nitrogen-containing compounds in-
cluding aliphatic and aromatic amines, indole and imidazole through
CeO activation of phenol derivatives (aryl carbamates and sulfamates)
in the presence of Fe3O4@SiO2-EDTA-Ni(II) NPs. The main benefits of
the application of phenolic derivatives in the N-arylation reaction are
being highly rewarding because these compounds serve not only as
more eco-friendly alternatives rather than aryl halides and also, they
can be easily produced from cheap and available phenols. The other
features of this catalytic system are the significant improvement of the
substrate and functional group tolerance, high selectivity, en-
vironmentally friendly, and being economical, recoverable and reusable
compared to previously published methods. Despite these unique fea-
tures, this catalytic system has special applications in pharmaceutical
Appendix A. Supplementary data
Supplementary material related to this article can be found, in the
References
10